Pellets vs Injections
Pellets and injections are both provider-reviewed delivery modalities for hormone optimization. Pellets release steadily over 3–6 months from a subcutaneous insertion. Injections deliver weekly (or split twice-weekly) doses the patient self-administers. The right modality is matched against biomarker behavior, dose-adjustment flexibility, lifestyle, and continuity preference.
Choose pellets when low-touch continuity is the priority, when day-to-day variability has been a problem, and when the patient prefers fewer touchpoints between recalibrations.
Explore pathwayChoose injections when tight dose adjustability and faster recalibration matter, when the patient wants direct control of the cadence, or when biomarker behavior needs frequent fine-tuning.
Explore pathwayEducational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Are creams another option?
Yes. Transdermal testosterone cream is a third modality with its own absorption and biomarker profile, and is part of the same provider-reviewed decision. See the TRT Injection vs Cream comparison.
Can modalities be switched?
Yes — switching is provider-reviewed against biomarker response, lifestyle, and goals. It is not a self-directed change.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment
